Impact of a Capillary Refill Time–Guided Personalised Hemodynamic Resuscitation Protocol in Septic Shock in Low- and Middle-Income Countries: A Post Hoc Analysis of the ANDROMEDA-SHOCK-2 Trial
A post hoc analysis of the ANDROMEDA-SHOCK-2 trial demonstrates that capillary refill time–guided personalized hemodynamic resuscitation yields consistent and significant benefits for patients with early septic shock in both low- and high-income countries, despite marked differences in baseline severity and resuscitation practices.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Sepsis is a life-threatening reaction where the body's own defenses turn against an infection, often leading to a dangerous drop in blood pressure and a failure of vital organs. When this escalates to septic shock, the body's tissues are starved of oxygen, and doctors must act quickly to restore blood flow. For decades, a common way to measure whether treatment is working has been to check the level of lactate, a chemical that builds up in the blood when cells are struggling to get enough oxygen. However, lactate levels can sometimes be slow to change or influenced by other factors, leaving doctors guessing about the true state of a patient's circulation. A simpler, older method involves checking capillary refill time, which is done by pressing a finger on a patient's skin until it turns white and then timing how long it takes for the pink color to return. This quick test offers a direct window into how well blood is reaching the smallest vessels in the body. While this method is easy to perform and requires no expensive equipment, it has rarely been tested as the primary guide for treating the most severe cases of shock, especially in regions where advanced medical technology is scarce.
A recent analysis of a large international study called ANDROMEDA-SHOCK-2 sought to determine if using this simple skin test to guide treatment could save lives and reduce the need for machines that support breathing and kidneys. The researchers focused specifically on patients in low- and middle-income countries, where the burden of sepsis is often higher and resources are more limited. They compared two groups of patients: one group received standard care, where doctors adjusted fluids and medications based on traditional measures, while the other group was treated using a personalized protocol where doctors adjusted therapy hour by hour based on the capillary refill time. The goal was to see if this direct, low-tech approach could outperform standard methods in settings where high-tech monitoring might not be available.
The study involved nearly 1,500 patients across 86 intensive care units in 19 countries. The researchers found that the patients treated in low- and middle-income countries were generally younger and had higher levels of lactate at the start of their treatment compared to those in wealthy nations. Despite these significant differences in the patients' starting conditions and the different ways hospitals usually manage shock, the results were remarkably consistent. Patients in both wealthy and less wealthy countries who received the capillary refill time-guided treatment fared better than those receiving usual care. Specifically, the treatment helped patients recover faster from the need for vital organ support, such as ventilators or dialysis, and shortened the time they spent in the hospital. The data showed no evidence that the effectiveness of this approach depended on the wealth of the country; the benefit was present regardless of whether the hospital was in a high-income nation or a lower-income one.
While the overall success of the method was clear, the researchers dug deeper to see if certain types of patients or hospitals benefited more than others. They discovered that within the low- and middle-income countries, the treatment worked best for patients who started with very high levels of lactate, specifically those above 4 millimoles per liter. For these patients, the improvement in outcomes was particularly strong. In contrast, the benefit was less pronounced for those with lower lactate levels. The study also looked at the hospitals themselves and found that the size of the intensive care unit and whether it was a public or private facility mattered more than the country's income level. Patients in public hospitals and those in medium-sized units saw the greatest gains, suggesting that the local capacity and resources of a specific hospital are better indicators of how well a treatment will work than the general wealth of the nation.
The findings suggest that a simple, low-cost physical exam can be a powerful tool for guiding life-saving treatment, even in the most resource-limited settings. The study did not find a statistically significant reduction in the number of deaths overall, but it did show a clear reduction in the duration of organ support and hospital stays, which are critical measures of recovery. The researchers noted that the high use of vasopressin, a drug that constricts blood vessels to raise blood pressure, was much more common in the low- and middle-income countries, yet the treatment protocol still worked effectively. This indicates that the approach is robust enough to handle different medical practices and patient profiles. Ultimately, the study provides strong evidence that in the fight against septic shock, looking at the blood flow in a patient's fingertips can offer guidance that is just as reliable as complex monitoring, offering a practical and effective strategy for hospitals everywhere.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.